Showing results (821-830 of 2,061) with videos related to
Sort By:
Pageof 207
Brachytherapy|November 17, 2020
The impact of a rectal hydrogel spacer on dosimetric and toxicity outcomes among patients undergoing combination therapy with external beam radiotherapy and low-dose-rate brachytherapyAnthony D Nehlsen, Kunal K Sindhu, Erin Moshier, et al.Brachytherapy|February 17, 2020
Influence of tumor shape and location in eye plaque brachytherapy dosimetryMatthew T Studenski, Nirav V Patel, Arnold Markoe, et al.Brachytherapy|November 7, 2019
Transperineal mapping biopsy improves selection of brachytherapy boost for men with localized prostate cancerNelson N Stone, Vassilios Skouteris, Panagiotis-Marios MetsinisBrachytherapy|December 23, 2014
Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator positionKaren S Nkiwane, Richard Pötter, Lars U Fokdal, et al.Brachytherapy|December 12, 2018
Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapySo-Yeon Park, Seonghee Kang, Jong Min Park, et al.Brachytherapy|August 16, 2017
Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapyJohn V Hegde, D Jeffrey Demanes, Darlene Veruttipong, et al.Brachytherapy|January 23, 2019
Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS)Christine H Holschneider, Daniel G Petereit, Christina Chu, et al.Brachytherapy|October 28, 2017
The American Brachytherapy Society consensus statement for accelerated partial-breast irradiationChirag Shah, Frank Vicini, Simona F Shaitelman, et al.Brachytherapy|August 29, 2017
Low-dose-rate prostate brachytherapy: 4-8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free survivalCameron M Callaghan, Lin Wang, Abhishek Alluri, et al.Brachytherapy|January 15, 2018
Validation of MRI to TRUS registration for high-dose-rate prostate brachytherapyEric Poulin, Karim Boudam, Csaba Pinter, et al.Pageof 207